I think a clear set of next steps is what the market is missing here - with LuPiN we went from the dangling of the Novartis carrot to being approached by other radioligand companies to just not sure where it’s at. i feel like the SP has ebbed and flowed with the LuPin story after hitting 99c and now halving from there. Otherwise it’s snakes and ladders without a cohesive plan to commercialise.
NOX Price at posting:
49.5¢ Sentiment: Hold Disclosure: Held
